CA2316052C - Formules de peptides hydrosolubles a liberation continue - Google Patents

Formules de peptides hydrosolubles a liberation continue Download PDF

Info

Publication number
CA2316052C
CA2316052C CA002316052A CA2316052A CA2316052C CA 2316052 C CA2316052 C CA 2316052C CA 002316052 A CA002316052 A CA 002316052A CA 2316052 A CA2316052 A CA 2316052A CA 2316052 C CA2316052 C CA 2316052C
Authority
CA
Canada
Prior art keywords
sustained release
release formulation
formulation according
octreotide
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002316052A
Other languages
English (en)
Other versions
CA2316052A1 (fr
Inventor
David Bodmer
Jones W. Fong
Thomas Kissel
Hawkins V. Maulding
Oskar Nagele
Jane E. Pearson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to CA002535463A priority Critical patent/CA2535463A1/fr
Priority claimed from CA002020477A external-priority patent/CA2020477C/fr
Publication of CA2316052A1 publication Critical patent/CA2316052A1/fr
Application granted granted Critical
Publication of CA2316052C publication Critical patent/CA2316052C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA002316052A 1989-07-07 1990-07-05 Formules de peptides hydrosolubles a liberation continue Expired - Lifetime CA2316052C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002535463A CA2535463A1 (fr) 1989-07-07 1990-07-05 Octreotide-pamoate et son utilisation dans des formulations de peptides hydrosolubles a liberation prolongee

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US37702389A 1989-07-07 1989-07-07
US377,023 1989-07-07
US41134789A 1989-09-22 1989-09-22
US411,347 1989-09-22
CA002020477A CA2020477C (fr) 1989-07-07 1990-07-05 Formules de peptides hydrosolubles a liberation continue

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002020477A Division CA2020477C (fr) 1989-07-07 1990-07-05 Formules de peptides hydrosolubles a liberation continue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002535463A Division CA2535463A1 (fr) 1989-07-07 1990-07-05 Octreotide-pamoate et son utilisation dans des formulations de peptides hydrosolubles a liberation prolongee

Publications (2)

Publication Number Publication Date
CA2316052A1 CA2316052A1 (fr) 1991-01-08
CA2316052C true CA2316052C (fr) 2008-09-02

Family

ID=27168773

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002316052A Expired - Lifetime CA2316052C (fr) 1989-07-07 1990-07-05 Formules de peptides hydrosolubles a liberation continue

Country Status (1)

Country Link
CA (1) CA2316052C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005101466A2 (fr) * 2003-12-19 2005-10-27 The University Of North Carolina At Chapel Hill Procede de fabrication de microstructures et de nanostructures au moyen de la lithographie molle ou d'impression
PE20090387A1 (es) * 2007-05-24 2009-04-28 Novartis Ag Formulacion de pasireotida
PT2247282E (pt) 2008-01-30 2014-11-11 Novartis Ag Formulação de libertação controlada compreendendo octreotido e três polímeros lineares de polilactido-coglicolido
CN111514118B (zh) * 2020-05-06 2022-04-19 南京林业大学 一种葡萄糖改性的聚乳酸立构复合物载药微球制备方法及产品

Also Published As

Publication number Publication date
CA2316052A1 (fr) 1991-01-08

Similar Documents

Publication Publication Date Title
CA2020477C (fr) Formules de peptides hydrosolubles a liberation continue
US5876761A (en) Sustained release formulations of water soluble peptides
US5688530A (en) Sustained release formulations of water soluble peptides
CA2746968C (fr) Formulation a effet retard d'octreotide avec niveaux d'exposition constamment eleves
WO2009095450A1 (fr) Préparation à libération soutenue comprenant de l'octréotide et trois polymères linéaires polylactide-co-glycolide
CA2316052C (fr) Formules de peptides hydrosolubles a liberation continue
CA2654113A1 (fr) Formulations a liberation prolongee d'inhibiteurs de l'aromatase
CA2535463A1 (fr) Octreotide-pamoate et son utilisation dans des formulations de peptides hydrosolubles a liberation prolongee
IL112286A (en) Process for the production of a microparticle and microparticle obtained thereby
FI106926B (fi) Menetelmä pitkäaikaisesti vapautuvan koostumuksen muodostamiseksi
NL195090C (nl) Preparaten van in water oplosbare peptiden met een langzame afgifte.
SA90110050B1 (ar) مستحضرات ممتدة المفعول لببتيدات تذوب في الماء

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry